Review Book Flashcards

(664 cards)

1
Q

TCR complex

A

TCR (alpha/beta or gamma/delta)
Cd3 (epsilon/delta and gamma/epsilon),
2 zeta chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NKT cell recognize

A

Lipids in context of Cd1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Costimulatory signal in t cell activation

A

Cd28 (T cell receptor) with B7-1 (cd80) or B7-2 (cd86)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T cell survival signal

A

IL-2 with its receptor CD25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cd80/86 increased/decreased by:

A

Increased by PAMPs/bacterial products detected by dendritic cells

Decreased by CTLA-4 that pushes out cd28 and binds cd80/86, downregulating it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mutation causing x-linked lymphoproliferation syndrome (XLP)

A

Mutation in SAP
SAP binds SLAM and links SLAM to Fyn (linked to cd3 proteins) on activated T cells

EBV in boys with XLP can develop HLH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Zap-70 deficiency cell enumeration

A

No Cd8 cells
No T cell function
Normal B cells
Normal NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T cell activation signaling sequence

A
  1. Antigen binds TCR (via MHC)
  2. Lck phosphorylates cd3 and zeta proteins, recruiting zap-70
  3. Zap-70 phosphorylates LAT
  4. Lat becomes docking site for PLC-1 and Grp2
  5. Grp2 recruits sos that catalyzes GDP to GTP on RAS —> Mek>erk>Fos>ap-1 transcription factor
  6. PLC converts pip > DAG and ip3, activates:
    A. DAG -> PKC -> NFkB
    B. IP3 -> increased intracell Ca via CRAC on cell membrane -> calmodulin >calcinuerin > NFAT > cytokine transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BCR complex components

A

Surface immunoglobulin
Ig alpha and Ig beta chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BCR signaling cascade

A
  1. Lyn P itam (Igalpha/beta), docking for Syk
  2. Syk (~zap-70 analogue) P BLNK
  3. BLNK activates ras, rac, plc, btk, grb-2
  4. Btk + Syk activate PLC -> PIP2 into ip3/DAG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How complement enhances BCR

A

Antigen opsonized with c3b > degraded to c3d
C3d ligand for cd21(cr2) on B cells
Forms complex - cd21-cd19-cd81
- when binds c3d, complex goes to BCR and activates cascade with enhanced response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inhibitory receptors in T, B, and NK cells

A

T cells - ctla-4, pd-1
B cells - fcgammaRIIbeta
NK cells - KIRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NFkB activators

A

IL-1, TNF, IL-17, TLR activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antiviral Cytokines

A

Type I interferon (IFNalpha/beta), IL-28A, IL-28B, IL-29

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cellular immunity cytokines

A

IL-2, , ifn gamma, IL-15, IL-17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Humoral immunity cytokines

A

IL-7, IL-11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anti-inflammatory cytokines

A

TGF-beta, IL-10, il-37, il-38

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cytokines in isotope switching

A

IL-4 and -13 — IgE
Tgf-beta, il-5 — IgA
Il-10 — igg4
IFN-g - IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

TNF actions

A

Acute inflammation (esp GNR)
Recruits neutrophils/monos
Stimulates endothelial cells to express adhesion molecules and induce chemotaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lymphotoxin action

A

Activates endothelial cells and neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

BAFF action

A

Survival signals to maturing B cells
Upregulates anti-apoptotic Bcl-2 activation of NFkB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

APRIL cytokine action

A

Upregulates anti-apoptotic Bcl-2 activation of NFkB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Il-1 action at high and low concentrations

A

Low - local inflammation, endothelial cells increase surface molecules for leukocyte adhesion

High - fever, synthesis acute phase reactants in the liver, neutrophil/plt production in bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

IL-18 source

A

Macrophages
Dendritic cells
Pro-molecules cleaved by caspase-1
NOT made by T, B, or NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Il-18 actions
- IFN-gamma production by T and NK cells - inhibits IgE synthesis
26
IL-33 actions
Alarmin (w/ TSLP, Il-25) T cells - Th2 development ILCs - activate group 2 ILCs
27
Il-37 action
With SMAD3 in nucleus - inhibits transcription pro-inflammatory mediators
28
Anakinra target
Binds IL-1R (IL-1Ra) to prevent Il-1 pro-inflammation in autoinflammatory syndromes
29
IRAK-4 deficiency infections
Pyogenic infections, esp strep pneumonia
30
Il-19 action
Activates monocytes to release il-6, TNF-alpha, ROS promotes Th2
31
Il-22 action
From Th-17 cells Epithelial cells increase defensins and barrier function Induces MHC class I antigen expression
32
IL-12 actions
- Stim ifn-gamma production by T and NK cells - promotes Th1 cells (that produce ifn-gamma) - increases production il-18 receptor (il-18 aka ifn-gamma inducing factor)
33
Il-23 actions
- important in protection klebsiella PNA - promotes differentiation/maintenance Th17 cells (that produce il-17)
34
Il-27 action
- Promotes Th1 - promotes ifn-gamma production by t cells
35
Type I ifn action (Ifn-alpha, -beta)
- inhibit viral replication - increase class I MHC expression - stimulate Th1 cells - promote sequestration lymphocytes in LNs
36
Il-7 action
Survival of T cells (esp cd4)
37
Il-21 action
Class switching and Ig production by B Cells
38
IL-2 action
- required for survival/function Tregs - proliferation of NK cells - induces Bcl-2 expression
39
IFN-gamma action
- Promotes Th1 differentiation - Inhibits Th2 differentiation - Inhibits class switch IgE, IgG4 - increases MHC on APCs - promotes macrophage inflammation and inhibits IgE-dep eosinophil rich reactions
40
il-16 action
Promotes Th1/dampens Th2
41
Il-17 action
- increases th17 - increases chemokines/cytokines - increases gm-csf and g-csf
42
Il-25 action
Alarmin Increases il4, 5, 13
43
Il-4 action
- th2 differentiation - class switch to IgE and IgG4 - it’s receptor, il-4R signals through Jak-stat (stat6)
44
Il-5 action
- activates eos - B cell proliferation and IgA production
45
Il-13 action
- fibrosis as tissue repair of chronic inflammation - mucus by lung epithelial cells - IgE and IgG4 class switching
46
Il-6 action
- pro-inflammatory - stimulates acutely phase protein synthesis in liver - production neutrophils in BM - T cells to produce il-17 - signaling involves jak1/stat3
47
Il-15 action
- survival of memory CD8 T cells, NK cells, NKT cells
48
TGf-beta
- anti-inflammatory cytokine - inhibits proliferation/function T cells - inhibits macrophage activation - induces apoptosis - regulates tissue repair and activates fibrosis - uses Smad receptors
49
Gm-csf action
Promotes granulocytes, monocytes, macrophage activation
50
M-csf action
Promotes monocytes maturation
51
G-csf action
Granulocyte maturation
52
IL-33 action
Th2 development Activates group 2 ILCs
53
Il-3 action
- promotes mast cell development BM - basophil-differentiating cytokine - eos development
54
C-kit ligand action
- mast cell growth factor - sustains viability T cells in thymus
55
Castleman’s disease
Overproduction Il-6 LN hyperplasia, Fever, microcytic anemia, LAD, hypoalbuminemia, high CRP
56
Role of cytokines IL-1 -5
Hot T-Bone stEAk Il-1 - fever Il-2 - stimulates T cells Il-3 stimulates bone marrow Il-4 stimulates IgE Il-5 stimulates IgA
57
X-linked SCID receptor mutation
GammaC, part of IL-2R. Important for il-2r, il-4r, il-7r, il-9r, il-15r, -il-21r
58
Il-2R components
Il-2Ralpha Il-2R beta GammaC Engages jak3-stat5
59
Source of chemokines
Epithelial cells, endothelial cells, leukocytes, fibroblasts
60
Chemokines assoc w/ atopy
CCL2, CCL5, ccl7, ccl11 Cxcl8
61
WHIM syndrome
Warts Hypogamm Infections Myelokathexis (retention neutrophils in BM) Assoc w/ defects in CXCR4
62
CC chemokines
Recruits eos, monos, basos Lymphocytes for ALLERGY
63
CXC chemokines
Recruits Neutrophil Lymphocytes for INFLAMMATION
64
Ccl5 (RANTES) receptor
CCR 1,3,5
65
CCL11 (eotaxin) receptor
CCR3
66
CCL17 (TARC) receptor
CCR4
67
CXCL8 (IL-8) receptor
CXCR 1,2
68
Selectins role
Rolling of leukocytes and binding carbs
69
P-selectin summary
Aka CS62**P** On **P**latelets, ligand **P**GSL (and sialyl-lewis), binds **P**mns, T cells, monocytes
70
E selectin summary
Aka CD62**E** and ELAM On Endothelium Binds ESL-1, cd15, pgsl, sialyl lewis Homes T cells to sites inflammation
71
L selectin
Aka **L**AM-1, CD62**L** On Lymphocytes Leukocytes Ligands gLycsm-1, madcam-1, cd34, Sialyk-lewis Homes to LN HEV (via Glycam) and PMN rolling (via madcam)
72
LAD-2 deficiency and selectins
PMNs can’t express carb ligands for E and P selectin
73
Role beta integrin family (alpha4beta7)
Gut homing Binds madcam
74
Chemokine in heparin induced thrombocytopenia
Cxcl4
75
HIV chemokinea
CCR5 if homozygous mutation - no HIV infection If heterozygous - slow infection progression CXCR4 CCL3L1 - if low level, higher HIV acquisition and worse disease
76
Atherosclerosis chemokine
CXC3CL1 CX3CR1 - v249I mutation —> increased risk acs - T280M —> protects against plaque
77
Glanzmann’s thrombasthenia chemokine
GIIbIIIa defect leads to plt defect
78
Alternative pathway C3 convertase
C3bBb Stabilized by properidin
79
Alternative pathway activation
C3 tick-over to C3b in microbial surfaces
80
Only known positive regulator of complement system
Properidin Stabilizes factor B
81
Classical pathway activation
Antigen-Ab complex binds C1 (Binds CH2 domain IgG or CH3 of IgM)
82
Classical pathway c3 convertase
C4b2a
83
Binding affinity order of c1q for immunoglobulin
IgM > IgG3 > IgG1 > IgG2 Cannot bind IgG4
84
Involved pathway if love C3 and C4
Classical pathway activation
85
Lectin pathway activation
MBL binds mannose on microbial polysaccharides and MBL-assoc protease 1 (MASP-1, and MASP-2)
86
Lectin pathway enzyme that cleaves to create c3 convertase
MASp-2 cleaves c4 and c2
87
Lectin pathway convertase
C4bC2a (Same as classical)
88
C5 convertase
C3bBbC3b in AP C4b2aC3b in CP and LP
89
MAC
C5b-c8 polyC9
90
Inhibitors of MAC formation on complement cascade
S protein and CD59
91
Complement anaphylotoxins
C5a C4a C3a Induce inflammation and vascular permeability
92
C5a role
Most potent mediator basophil and citaneois mast cell degranulation (>c3a>c4a) Chemoattractant C3a chemotactic for eos only
93
CR2 (cd21) role in complement
Binds c3d and is a 2nd signal for B cell activation Decreases antigen any needed for B cell activation. Hemos trap ag-ab complexes in germinal centers Receptor for EBV
94
Complement receptor CR1(cd35)
Binds c3b, c4b Regulates c3 convertase dissociation Phagocytosis of c3b and c4b coated particles Clears immune complexes (cr1 on RBCs) HIV uses to infect monocytes
95
Complement receptor cr2 (cd21)
Binds c3d Keeps ag-an complexes in terminal centers for B cell activation EBV uses to facilitate cell entry
96
Complement receptor cr3 (cd11b/cd18)
Binds iC3b, Icam-1 Phagocytosis and leukocyte adhesion to endothelial cells LAD 1 Mediates phagocytosis M tuberculosis
97
Complement receptor cr4 (cd11c/cd18, gp150/95)
Bjnds iC3b Phagocytosis Lad type 1
98
Cd46 (mcp)
Cofactor to factor I, inactivated C3b and C4b Assoc w/ aHUS
99
CD55 (DAF)
Binds c3b c4b Prevents Bb binding c3b Prevents 2b binding c4b
100
CD59
Prevents c9 binding C5b-8
101
C3 nephritic factor
Autoantibodies that stabilize c3bBb Consumption of c3 Assoc w/ c3 glomeruloneohropathy and partial lipodystrophy - subendothelial deposits Ig and C3 Lipodystrophy - adipose source of factor D, completes formation c3bBb (Lipodystrophy affects waist up, where more adipocytes) Clue - low c3/nml c4 (alternative pathway)
102
Anti-c1q autoantibodies
Auto ab to c1q In hypocomplementemic urticarial vasculitis (huvs) Immune complex deposition skin, joints, kidneys, lungs Tx = hydroxychloroquine, dapsone steroids
103
Infxn assoc w/ terminal Complement deficiency
Neisseria
104
Issues w/ early classical complement pathway deficiency
Encapsulated orgs (strep pneumonia!) Lupus **Accelerated atherosclerosis** (Early mi second cause death)
105
Deficiency if: Ch50 absent Ah50 ok
Low C1q, c1q, c1q, c2, c4
106
Deficiency if Ch50 nml Ah50 absent
Low factor D, factor b, properidin
107
Deficiency if Ch50 absent Ah50 absent
Low c3, c5-c9 If c3 absent —> low factor H or I
108
Complement deficiency in sle
C1q >>> Also see low c1/s, c4, c2
109
MBL deficiency infxns
Pyogenic
110
Demographic c9 and c2 deficiencies
C9: 1/1000 Japanese C2: 1/10,000 caucasian
111
Complement deficiency assoc w/ age related macular degeneration
Factor H
112
Inhibitor factor XIIa
C1 inhibitor Therefore inhibits kallikrein production and bradykinin
113
Factor XIIa inhibitor
C1 inhibitor, therefore decrease kallikrein and bradykinin
114
Factor XIIa inhibitor
C1 inhibitor, therefore decrease kallikrein and bradykinin
115
Type II hypersensitivity examples
Cell antigens Hemolytic anemia Good pastures
116
Type III hypersens examples
Sle GN Serum sickness Arthur’s rxn Immune complexes
117
Mediators type II hypersens
IgG and IgM + complement/phagocytes
118
3 mechanisms type II hypersensitivities
1- opsonization (IgG) and phagocytosis (FcepsilonRI) (eg hemolytic anemia) 2 - complement activation (eg goodpasture) - IgG/M activate classical complement Anti-basement membrane 3 - abnormal response w/o injury (MG, Graves)
119
Arthus rxn
Local vasculitis from immune complexes deposition (type III hypersens) Local edema, neutrophil infiltration, hemorrhage, necrosis Peak intensity 4-10hrs
120
Serum sickness rxn
Type iii hypersens Rash, joint swelling, LAD, fever 7-12d after trigger start Kidneys, liver, hemolysis Re-exposure, sx onset 12-36 hrs
121
Type iii hypersens
Immune complex deposition - vasculitis - sle - GN - serum sickness
122
Type iv hypersens (cell-mediated)
Iva - cd4 th1 (ifn-gamma), TNF a, il2); macrophages, NK cells — contact dermatitis, TB IVb - cd4 Th2 — eos, B cells — DRESS, morbillifirm drug rash IVc — cd8, perforin, granzyme — psoriasis, drug induced Hep B IVd — T cells — neutrophils — contact derm, agep
123
2 types NK cells
Cd56bright - 10%, cytokine producing Cd56dim - 80%, activated
124
Antimicrobial peptide examples
Cathelicidins Defensins Produced by keratinocytes
125
Cytokines released from neutrophils
Il-1a, Il-12, -23, APRIL, BAFF
126
Cytokines from monocytes
TNF-alpha, Il-1, Il-6, Il-8, il-12
127
Dendritic cell cytokines
Il-1, il-6, il-23, TNF
128
Eosinophil proteins
Major basic protein Eosinophil cationic protein
129
Mast cell cytokines
Ifn gamma, il6, TNF alpha, tgf beta, PAF, tryotase
130
Basophil cytokines
Il-4, il-6, BAFF, tslp
131
NK cell cytokines
TNF alpha, il-10, ifn-gamma
132
DAMPs
Damage associated molecular patterns Endogenous molecules released by injured cells (NOT from apoptosis)
133
PRR (patent recognition receptors)
In APCs Recognize DAMPs and PAMPs
134
Cytokines that require cleavage by inflammasome to be activated
Il-1 and Il-18
135
TLR ligands
PAMPs Activate innate immunity
136
TLR that recognizes RSV and rhinovirus
TLR 2, 6, 7
137
TLR 4 ligands
GNR (lipopolysaccharides) , GP bacteria (peptidoglycans), rsv, acute phase proteins (Hsp 70, 90)
138
Adaptor protein involved in all TLR signaling (except TLR3)
MyD88 Activates NFkB and AP-1
139
TLR3 signaling mediators
TRIF, TRAF Activates IRF3 and IRF7, induce type I IFN
140
Endosomal TLRs
Live in a NEST Nine Eight Seven Three Play big role in viral recognition
141
TLR affected with hav encephalitis
TLR3
142
TLR pathway with Pyogenic infections
MyD88, IRAK4
143
NEMO deficiency
Canonical incisors, ectodermal dysplasia, recurrent bacterial infections IKKgamma
144
Chronic mucocutaneous candidiasis deficiency
CARD9 - (cascade activation and recruitment domain), part of inflammasome
145
Cryoporin associated periodic syndromes (caps) mutation
NLRP3 - inflammasome
146
Central tolerance T cells
Via AIRE in MTEC
147
B cell central tolerance (negative selection)
Receptor editing with help RAG1/2 and light chain rearrangement
148
Thymus develops from which branchial arch
3 and 4
149
T cell positive selection
If bind strongly enough to peptides bound by MHC on **cortical** Thu if epithelial cells
150
T cell negative selection
AIRE induces expression self antígena Occurs in **medulla** (Negative selection in cortex)
151
When do T cell lose double positivity (cd4+cd8+)
When leave cortex and go to medulla
152
How do naive T cells home to parafillocular zone in T cells
Their CCR7 (on mature naive T cells) binds ccl19/21 from dendritic cells/stromal cells
153
How do T cells leave LN?
Via S1P gradient
154
What do Gamma delta T cells recognize
Lipids and heat shock proteins
155
Where are Gamma delta T cells found?
Gut tissue
156
NK T cell recognize and produce?
Recognize glycolipids Produce ifn gamma, IL-4, -3, -17
157
What cytokines induce, are produced by, transcription factors of Th1
Induced by il12, ifn gamma Produce ifn gamma Txn factor Tbet, stat4 For intracellular defense
158
What cytokines induce, are produced by, transcription factors of Th2
Induced by il4, Produce il4, 5, 13 Txn factors gata3, stat6
159
What cytokines induce, are produced by, transcription factors of Th17
Induced by il-6 Produces il-17, Txn factor RORgammaT, stat3 Extracellular defense Psoriasis
160
What cytokines induce, are produced by, transcription factors of Th9
Induced by tgf beta Produces il9
161
What cytokines induce, are produced by, transcription factors of Tfh
Induced by/produces il-21 Txn factor bcl-6 Helps B cells make antibodies
162
What cytokines induce, are produced by, transcription factors of Tregs
Induced by tgf-beta Produces tgf-beta, Il-10 Txn foxp3, stat5
163
3 types Treg
Natural T regs in thymus - mediate self tolerance Induced Treg (Tr1) in periphery - suppress effector cells iTreg (Th3) - in periphery, help IgA production in gut
164
Where are B cells first produced in fetus
Fetal liver @7eks
165
How mature naive B cells enter LN
Express cxcl5 that binds cxcl13 expressed by follicular dendritic cells i
166
How follicular naive B cells in LN follicles move to border with T cells
Activated by antigen presenting dendritic cells, increase ccr7 expression
167
Which interaction needed to stimulate B cell switch recombination (class switching)
Cd40 (b cell) with cd40L (follicular helper T cell) Also need AID and UNG
168
HyperIgM causes
Deficiencies in cd40, cd40L, AID, UNG Ig gets stuck in IgM form (doesn’t have tools for class switching CD40L on T cells affected
169
Somatic hypermutation (affinity maturation)
T cell dep (need cd40-cd40L) In germinal center Point mutations in V regions
170
Peripheral B cell survival signals
BLYSS, APRIL, BAFF receptors on B cells are BR3, TACI, BCMA
171
Role of Tdt Terminal deoxynucleotidyl transferase
Adds nucleotides randomly during vdj recombination At hairpins Responsible for heterogeneity
172
B 1 B cells
In peritoneal cavity and fetus Independent of T cells Doesn’t need antigen - constitutive secrete Ig
173
What has vdj recombination
Ig Heavy chains and TCR beta
174
12/23 rule
In vdj recombination, a gene segment flanked by 12 nt spacer can only be joined by gene segment flanked by 23 nt spacer
175
RSS
Recombination signal sequences 12 or 23nt long
176
Role rag1/2
Align 2 RSSs Cleave dsDNA between coding segment and RSS
177
Artemis
Opens hairpins at coding ends (with DNA-pk Vdj rearrangement
178
DNA ligase IV /XRCC4
Ligate coding and rss joints
179
Lymphocyte pro-apoptotic proteins
Intrinsic - Bim binds Bax and bak to activate caspase 9 Extrinsic - FasL binds Fas, activates caspase 8
180
Lymphocyte apoptosis pathways converge on ___ to lead to apoptosis
Caspase 3
181
Cytokines that stimulate NK cells
Ifn alpha, beta, il12
182
Cytokine needed for NK cell development
IL15
183
ILC in allergy
Ilc2 recruited to lung and skin after allergen, il5 dep eos recruitment, il13 smooth m contraction, mhc II th2 enhancement —> allergy and fibrosis ILC3s -> increased in BAL of asthmatics
184
FCepsilonRI is expressed on 2/3: Mast cells Basophils Eosinophils
Not on eosinophils
185
Cytokines stimulating differentiation of mast cells, basos, eos
Stem cell factor - mast cells Il-3 to basos Il-5 to eos
186
Mast cell progenitors and where develop
Ckit+ (cd117), cd34+ stem cells Develop after arrival in tissue
187
Progression of mast cell mediator release
<15 mins - preformed mediators (tryptase, histamine, heparin, chymase) 10-30mins - lipid mediators (PGD2, LTC4, LTB, paf) Hrs-days - cytokines and chemokines
188
FCeRI binding IgE
Mast cell activation Alpha, beta, and 2 gamma chains IgE binds via alpha chain
189
Peak IgE in relation to pollen season
4-6wks after peak pollen season
190
Immunodeficiency with high IgE
Bullous pemphigoid WAS Omenn IPEX Atypical incomplete DiGeorge Netherton
191
MRGPRX2 receptor
Susceptible mast cells activated by this receptor with certain medications - cipro, atracurium, vanco, narcotics (except fentanyl)
192
Basophil receptor
CD123 (il-3 receptor) Il-3 important for expansion/differentiation
193
Eosinophils preformed mediators
Mbp, eos cationic protein, eos peroxidase, eos-derived neurotoxin
194
Markers on eos (flow cytometry)
Siglec-8, CCR3, EMRI
195
Eos Txn factor
GATA1
196
Chemokines that draw eos to tissues
RANTES (ccl-5) and eotaxin (eot-1/ccl11 and eotaxin-2/ccl24)
197
Eosinophilia level
>500 cells/ul
198
Eosinophilia ID ddx
Hyper-IgE Omenn IPEX Zap70 def Netherton synd
199
Most common cause eosinophilia in US worldwide
US - drug reactions WW - parasites (NOT protozoa - giardia, amoeba)
200
Eos suppressed by
Fever, steroids, most viral/bacterial infxn (HIV raises eos)
201
Hyper eosinphilic syn criteria
eos >1500 x2 at least 4 wks apart AND end-organ damage OR tissue involvement
202
Causes eosinophilia
NIAAA Neoplasm Infection Allergic Autoimmune Adrenal insufficiency
203
Monocyte surface marker
CD14 (part of TLR4 and a LPS receptor)
204
Macrophage surface molecules
CD14, CD16, CD11b/CD18, CD33
205
Macrophage activation
Classical M1: Induced by LPS or Th1 cytokines (IFN-gamma), phagocytose and present antigen, secrete Th1 cytokines (TNFa, IL6, IL1beta _> T cell activation Alternative M2: induced by steroids and Th2 cytokines, reponse to parasitic infections
206
Macrophage activation syndrome/HLH
uncontrolled activation macrophages with increased cytokines. Predisposing ID and low NK cells + immune activation --> damage High fever, HSM, high ferritin and TG, low fibrinogen, hepatitis
207
HLH dx criteria
>/5 of the following: fever splenomegaly cytopenia in 2+ lines, hyperTG hypofibrinogenemia hemophagocytosis low/absent NK cels ferritin <500 soluble CD25 >2400 (activated T cells)
208
Plasmacytoid dendiritic cells
Marker CD123, secrete IFNa and are in viral infxn (unique dendritic cell subset, as no CD11c expression)
209
Langerhans cells
dendritic cell subset, marker CD11c, Birbeck granules Prime CD8 T cells
210
Dendritic cell maturation
Immature in the tissue, where uptake antigen Mature in lymphoid organ
211
CD1 isoforms
class I MHC like molecules that present nonpeptide molecules to T cells
212
Langerhans cell histiocytosis markers
Confirm LC identity on bx with CD1a and CD207
213
chemokines attracting neutrophils in tissue
IL-8 (CXCL8), LTB4 Also with sialyl-lewis, e-/p-selectings, LFA1/ICAL1
214
Color of basos, eos, neutrophils on H&E stain
Basos - basic blue Eos acidic, bright red Neutrophils neutral pink
215
ELANE mutation
affects CD11b in granulocyte elastase in neutrophils
216
Neutrophil granules
primary - MPO, defensins, cathelicidin/cathepsin Secondary - lysozyme, collagenase, elastase, lactoferrin, Cd11b
217
Chediak Higashi neutrophil granule change
Enlarged primary granules
218
heparin induced thrombocytopenia antibodies
against plt antigen PF4
219
WAS
eczema, infections, thrombocytopenia defective WASp gene
220
Steroid resistant asthma role smooth muscle
Airway smooth muscle unregulates glucocorticoid receptor (GR)-beta, a negative inhibitor
221
Required for B and T cell development
IL-7
222
B cell negative selection
Auto reactive/nonfunctional B cells removed
223
Parts of thymus
Subcapsular zone - lymphocyte progenitors Cortex - lymphocytes in division, expression, TCR section - positive selection with TCR re-arrangement compatible with MHC - negative selection begins in cortex - auto reactive/nonfunctional T cells/TCRs apoptose Medulla - where final stages selection/maturation - most of negative selection - has Hassles corpuscles
224
Cryopatches
T cell precursors that go to cryopatches instead of thymus - lymphoid aggregates under intestinal epithelium to form specialized T cell populations
225
2 follicle types in LNs
Primary - site resting B cells Secondary - germinal center of B cell proliferation Ratio primary to secondary LNs defines LN activity
226
Area of spleen where lymphocytes are
White pulp
227
Which cells only undergo negative selection
B cells T cells undergo positive and negative
228
Nasal airway resistance regulated by
Nasal valve, which is controlled by swelling inferior turbinate
229
Sinus development
Maxillary/ethmoid present at birth Sphenoid develop at 3yo Frontal at 6yo
230
Sinuses listen to FM AM PS SS
Frontal, maxillary, ant ethmoid drain into middle meatus Posterior ethmoid, sphenoid drain into sphenoethmoidal recess above superior turbinate
231
Lower airway changes asthma vs copd
Asthma: smooth m enlarged in LARGE airways, have increased cd4 and eos, increased il-5/4, Copd: enlarged smooth m in SMALL airways, increased acidic glycoproteins, cd8, NO increased il5
232
Mast cells in dermis express
Cd68
233
Homing cells to skin via
CCR4/ccl17 and ccr10/ccl27
234
Pemphigus vulgaris ab
IgG ab to desmoglein 1/3 Blisters flacid - erupt IgG and C3 staining on suprabasal layers
235
Bullous pemphigoid
Tense Prominent pruritus IgG BP180, bp230 Linear basement membrane IgG and C3
236
Dermatitis herpetiformis
Small bullae elbows/knees Pruritic Assoc w celiac IgA to epidermal transglutaminase
237
Fpies lab value acute episode
Increase neutrophils, elevated methemoglobin Friable mucosal with villous atrophy
238
EOE cytokines
Il-5, eotaxin -3
239
Labs to diagnose celiac
Gliadon sensitivity Anti-tTG IgA (tissue transglutaminase) Total IgA (if IgA deficient, false neg anti-ttg iga
240
Study type and statistic
Cross-sectional - prevalence Case-control - odds ratio Cohort (subjects with common characteristic - who develops dz) - relative risk Rct - absolute risk reduction, suggest causality
241
Type I (alpha) error
Falsely reject null hypothesis
242
Type II (beta) error
Falsely accept null (commonly from underpowered studies)
243
Odds ratio
Axd/ b x c (True pos x true neg) / (false pos x false neg)
244
Relativ risk
Incidence in exposed / inc unexposed Ppv / c/ c+d
245
Absolute risk
Number events in treated or control group / number people in the group
246
Elements informed consent
Competence, disclosure, understanding, voluntariness, consent
247
Risk factors allergic rhinitis
FHx atopy IgE > 100 before age 6 Increased SES Maternal smoking
248
Immediate allergic response Sx and their mediators
Histamine - itch, sneeze, rhinorrhea PGD2 and leukotrienes - nasal congestion Kinins- nasal congestion/blockage
249
Priming
Chronic inflammation leads to lower dose of allergen to elicit sx (AR)
250
First line tx perennial and seasonal AR
Perennial - intranasal steroids Seasonal - inteanasal antihistamines
251
Most effective med rhinorrhea
Jntranasal ipratropium
252
NARES
No allergic rhinitis w eosinophils Eos>20% on nasal smear Middle aged men Yr-rnd sx Abnml PG metabolism Tx - topical steroids
253
Gustatory rhinitis nerves
Stimulation sensory c-fibers Parasympathetic reflex, Chokinergic muscarinic receptors Tx - ipratropium
254
Atrophic rhinitis
Noninflammatory Progressive atrophy in middle aged men in warm countries (Saudi Arabia) Klebsiella colonization Foul smell nasal vault
255
Secondary atrophic rhinitis
Causes: multiple ess empty nose syndrome granulomatous disease
256
Rhinitis of pregnancy Tx
Intranasal corticosteroids are ineffective
257
AFRS
Eosinophilic process (mbp, Il-5, etc) Asymmetric? Peanut butter mucus (brown and viscous) Ct - central hypoattenuation Bony demineralization MRI - hyper intense areas in mucin (heavy metals iron mgn within mucin) - heterogenous opaciticTikn)
258
AFRS criteria
All 5: 1. Hypersens to fungi confirmed - asp., alternaría, curvularia, penicillium, fusarium, bipolaris 2. Nasal polyposis 3. Ct findings 4. Noninvasive fungus in mucin or in cx 5. Eosinophil mucin w/o invasión into sinus tissue
259
Vernal conjunctivitis
Sight threatening chronic conjunctiva inflammation Young males in warm dry climates Severe photophobia, intense itching Worse with antihistamines (increased dryness) +verna;/spring sx
260
Atopic keratoconjunctivitis
Sight threatening Commonly with a topic dermatitis Keratoconus Anterior subcapsular cataracts Gritty photophobia
261
Giant papillary conjunctivitis
From contacts mechanical trauma - protein buildup on lenses - allergic reaction Get redness, itching after contact removal, morning mucus discharge Tx - remove contacts and use artificial tears
262
Hordoleum versus chalazion
Hordoleum (stye) = pain Chalazion = not painful
263
Granulomatosis with polyangiitis eye findings
50% ocular sx Conjunctivitis, corneal ulcers, pain
264
Adult with new onset ad
Be concerned about cutaneous T cell lymphoma (ctcl)
265
Itch cytokine
Il-31 Induced by staph a
266
Cytokines reflective of AD severity
Cutaneous t-cell attracting chemokine (CTACK and ccl27) Thymus and activation regulated Chemokine (TARC)
267
Cytokines in acute and chronic AD
Acute - IL-4, -13 — th2, also il25 and -33 Chronic - Il-5, Il-12, ifn-g Il-17, -22 “Education is **chronic** starting at **5** through **G**rade **12** — th1
268
AD cell staining
Cd3, cd4, cd45ro, Activated eos Increased RANTES and TSLP decreased antimicrobial peptides
269
Lanngerhans cells
FcepsilonR1 lack classic beta chain Have Birbeck granules
270
Mucus plugs
Composed of serum, proteins, inflammatory cells, mucus and cellular debris
271
Asthma predictive index Risk school- aged asthma
>/4 wheeze episodes past yr PLUS 1 major - parent w/ asthma - AD - aeroallergens OR 2 minor - food sensitivity - peripheral eos (>/4%) - wheeze not related to infection
272
Aeroallergen sensitization to which is assoc w/ asthma pathogenesis
Cat, DM, cockroach, Alternaria
273
Post-bronchodilator response in asthmatics
Increase in fev1 and/or fvc > 12%
274
Methacholine challenge
PC <4 mg/ml diagnostic 4-16 suggestive
275
FeNo increasers/decreasers
Increase - viral uri - allergic rhinitis - nitrate-rich foods Decrease foods - caffeine - smoking - CF - alcohol - spirometry Eos stimulate epithelial cells to produce NO
276
Exercise induced bronchospasm
Sx onset after 10mins activity Resolves 15-30mins after Fev1 decrease at least 15% after exercise challenge
277
Egg allergen heat stable
Ovomucoid, gal d 1
278
Peanut allergen assoc w OAS
Ara h 8 (bet v 1 homologue)
279
Peanut allergens assoc w severe anaphylaxis
Ara h 12, 13
280
Soybean allergen w/ severe rxn
Gly m 5/6 Gly m 3/4 = bet v 1 homologues
281
Wheat allergen assoc w anaphylaxis
Tri a 19
282
Latex fruit syndrome fruits
Food allergies in 30-50% BACK banana, avocado, chestnut, kiwi
283
Birch OAS allergens
Stone, fruits, apple, almond, hazelnut, so I’ve been some peanuts, celery, carrots, fennel, coriander
284
Ragweed OAS
Melons, zucchini, banana
285
Mugwort OAS
Celery, carrot, parsley, mustard, cauliflower, cabbage, garlic, onion
286
Rate of food allergy outgrowth
Cows milk, soy, wheat, egg — 85% by age 5 Peanut - 20% Tree nuts - 9%
287
FPIES most common triggers
Milk, soy, rice, oat 50% outgrow after 2 yrs
288
Cellular changes in FPIES
Increased neutrophils and Il-10, TNF-g Decreased eos
289
FPIES dx
1 major + 3 minor Major: - vomiting 1-4 hrs after w/o IgE sx Minor - 2nd episode when eaten again - repetitive vomiting 1-4 hrs after eating different food - lethargy, pallor, ed visit requiring ivf - diarrhea, hypotn, hypothermia
290
Celiac genetics
HLA-DQ2 HKA-DQ8
291
Heiner’s syndrome
Recurrent PNA, pulm infiltrates, hemosiderosis,Fe def anemia, FTt Peripheral Eosinophilia Lung bx Milk precipitans Elimination diet
292
Leading causes anaphylaxis children and adults
Children - food and venom Adults - meds and venom
293
MRGPRX2
Receptor on mast cells. Can be directly activated by small molecular weight drugs - NBMAs, morphine, fluiriquinolone, vanco -> mast cell degranulation and non-IgE anaphylaxis
294
Cytokines that correlate with hypotn in anaphylaxis
Il-6 and -10, Tnf receptor 1 Mast cell tryptase Histamine C3a
295
Compound that correlates with anaphylaxis severity
PAF
296
Risk factors biphasic reactions
Severe initial reaction, Multiple doses epi Wide pulse P Delay in epi administration Unknown trigger
297
Drugs that prolong effect epi
TCAs - prevent catecholamine re-uptake MAOIs - prevent epi degradation
298
Ratio total tryptase to mature
Total/mature > 20 —-> mastocytosis Total/mature < 10 —-> other
299
Tryptase in anaphylaxis
Peaks 60-90’ Falls after 5 hrs Check 15’-3hrs after reaction Can confirm but not r/o anaphylaxis
300
Histamine peak in anaphylaxis
Rises w/in 5 mins, falls in 30-60’
301
Histamine receptors anaphylaxis
H1 - coronary artery vasoconstriction, bronchial construction, GI smooth m contraction H2 - coronary vasodilation, increased cardiac inotropy/chronotropy (rate, force) H1 and H2 - systemic vasodilation, flushing HA
302
Anaphylaxis treatment in patients on b-B
Epinephrine Glucagon and IVF if not responding - glucagon has inotropic and chronotropic effects not mediated by beta receptors
303
Most common peri operative anaphylaxis cause us
Antibiotics Europe - nmba
304
Latex allergens
Hev b 1-13 Hev b 2 - bell pepper, olive Hev b 5 - kiwi, potato, beet Hev b 6 - avocado, banana, chestnut, sweet pepper Hev b 7 - tomato potato Hev b 14 - potato 5-7 most common healthcare workers
305
Food-dep exercise induced anaphylaxis most common triggers
Celery Wheat (omega 5 gliadin), Avoid exercise 4-6hrs of ingesting food
306
Vespid species
Very aggressive Insects around garbage cans/food —> yellow jackets Common in autumn Most common cause of stings Hornets sting when vibration sensed
307
Hornet allergen
Dol m 5 - antigen 5
308
Polistinae
Paper wasp Narrow waist, dangling legs Pol a
309
Risk factor severe reaction to sting
No urticaria/angioedema Only 50% chance if reacted to prior sting will react to subsequent sting
310
VIT safety
50% have rxn in buildup phase 5-15% with systemic rxns <5% require epi
311
VIT efficacy
Reduces risk subsequent rxn to <5%
312
VIT indications
Anaphylaxis Can consider in large local reactions f impaired life, frequent exposures Not indicated: Large local rxn (4-10% risk systemic rxn) Urticaria/angioedema
313
Maintenance dose VIT
Adults - 100ug (can be increased to 200) Children - 59 if 300ug for mixed vespid Fire ants - whole body extracts
314
Skeeter syndrome
Large local reactions to mosquitos + fever
315
Chronic urticaria duration
At least six weeks
316
Cholinergic urticaria versus exercise induced anaphylaxis
EIA will not react with passive heating
317
Treatment of cold and local heat urticarial
Cold – cyproheptadine Heat – hydroxyzine
318
Urticarial vasculitis
Associate with a fever and or arthritis Typically painful and leave markings
319
Hypocomplementemic urticarial vasculitis syndrome (HUVS) criteria
Major (have both): - urticaria > 6 **months** - hypocomplementemia AND Minor (at least 2) - venulitis of dermis - arthralgia/arthritis - mild glomerulonephritis - uveitis/episcleritis - recurrent abdominal pain - positive c1q precipitan with assoc suppressed c1q (Anti-c1q ab)
320
Occupational asthma, versus reactive airway dysfunction syndrome
OA - latency period, Reactive - subset OA, occurs after single high level exposure, sx w/in 24 hrs. Eg gases
321
Common associations for occupational asthma
Carpenters/woodworkers - plicatic acid (activates complement) roofers/insulators/painters - isocyanates Nail salon/dental hygienists/plastics - acrylates, epoxy Manufacturers of paint, plastic, epoxy — anhydrides
322
OA dx
Measure pft at work and at home Fev1< 20% after exposure suggestive Methacholine challenge (neg test excludes OA) Gold standard - inhalation challenge
323
Three stages of hypersensitivity pneumonitis
Acute - hrs after exposure, - NONproductive cough, fever, chills malaise, - diffuse fine crackles - cr nml Subacute/intermittent - wks-mo - PRODUCTIVE cough, dyspnea, fatigue, wt loss - diffuse crackles - ct micronodules, air trapping, mild fibrosis Chronic - mo-yrs - cough, dyspnea, wt loss - digital clubbing - ground glass, emphysema, honeycombing, fibrosis
324
Farmers lung antigen
Thermophilic actinomycetes In moldy hay, grain, compost
325
Cigarette smoking, and hypersensitivity pneumonitis
Smoking decreases risk of HP
326
HP labs
CD8 predominance (cd4:8 < 1) Lymphocytosis>20% Increased eos, neutrophils, mast cells, IgA/G/M Noncaseating granulomas Decreased fev1, fvc, dlco
327
Organic dust, toxic syndrome (ODTS, pulmonary mycotoxicosis)
Noninfectious Febrile illness after exposure to dust with toxin-producing fungi (grain, hay, textiles) 30-50x more common than HP Complete recovery
328
ABPA dx
Need sensitivity to A fumigatus (Asp f 1) Elevated total IgE > 1000 When not responsive to abx
329
ABPA flare
Doubling of baseline IgE
330
COPD
FEV1/FVC < 70% after bronchodilation
331
GOLD criteria COPD
Gold 0 (at risk): sx but nml spiro Gold 1 (mild): fev1>/80% pred Gold 2 (moderate): 50-80% pred fev1 Gold 3 (severe): 30-50% pred fev1 Gold 4 (v severe): fev1<30% or <50% + chronic resp failure
332
Cells in copd
Neutrophils, macrophages, cd8 T cells Neutrophils/macrophages destroy alveolar attachments that help keep airway open and elastic recoil
333
Pan lobular emphysema
Copd type, assoc w alpha1 antitrypsin deficiency - think in young non-smokers with copd
334
Only disease modifying treatment and COPD
Smoking cessation
335
Life prolonging treatments, and COPD
Smoking cessation, supplemental oxygen 24 hours per day and lung volume reduction surgery
336
Copd vs ild
Copd - decreased Fev1/fvc - increases tlc - increased frc - clubbing uncommon - wheezing ILD - nml/increased fev1/fvc - decreased tlc - decreased frc - clubbing common - Velcro rales
337
Drug related ILD
Chemo - busulfan, bleomycin Abx - nitrofurantoin, sulfa Antiarrhythmics - amiidarone, procainamide Immunosuppressives - mtx, cyclophosphamide, azathioprine
338
IgG4-related lung dz
Increase IgG4 plasma cells and lesions in lung, liver, pancreas IgG4>135 Fibrosis
339
Contact hypersensitivity histology
Lymphocytes and spongiosis in upper dermis
340
Contact testing delayed tiggers
Corticosteroids, nickel, neomycin, gold
341
Allergic contact dermatitis vs irritant
Acd more pruritic, reactions increase between 1st and 2nd readings Icd - more prevalent, more stinging, reaction almost immediate and decrease between 1st and second readings
342
Mediators in contact dermatitis
IL1 alpha, IL1 Beta, TNF alpha, GM- CSF, IL8
343
Poison ivy dermatitis
Toxicodendron dermatitis To urushiol (an oleoresin) Cross reactivity to mango peels
344
Paraphenylenediamine
Most common cause Cd on hairdressers and henna tattoo
345
4 types corticosteroid classes
Group A - hydrocortisone type Group B - triamcinolone type Group C - betamethasone tupe Group D - hydrocortisone-17-butyrate type
346
Resins in ACD
Epoxy - sensitizing only when not cured Colophony - from pine trees, in cosmetics, topical meds, industrial products Ethylenediamine dihydrochloride - in topical creams, aminophylline Paraphenylenediamine (ppd) - from benzene, in henna
347
HAE type I Vs type II
Type I - decreased c4, low/absent c1 inh with decreased function; 85% cases Type ii - deceased c4 and increased/nml c1 inh that’s nonfunctional; 15% cases
348
Acquired c1-inh deficiency
Ab to c1-inh Assoc w nonhodgkins lymphoma Low c4 Low c1q C1 inhibitor low/normal C1 inh function decreased
349
T- B+ NK- SCID
Il2rg - gamma c def, x-linked, 50-60% of scids, cd132- Jak3 def - AR, cd132+
350
T- B+ NK+
IL7R - AR, 5% scids, no thymus Cd3E - ar, no game m/delta T Cd45 (ptprc gene) - ar, normal gamma/delta T cells, no thymus Coronin 1a def - coro1a - **normal** thymus
351
T-B-NK-
Ada def - ar, 20% scids, rachitic rosary, abnormal iliac bones, deafness Activated rac2 def - defective hematopoietic energy metabolism Reticular dysgenesis (ak2) - severe neutropenia, sensorineural deafness
352
T- B- NK+
Xlf def (nhej1) - microcephaly, facial dysmorphism, radiation sensitivity Artemis - DCLRE1C (Artemis), no microcephaly, AR
353
Omenn syndrome
RAG1/2 mutation, can't rearrange Ig genes Decreased B cells Erythroderma Increased lymphoid tissues HSM Eosinophilia, increased IgE Neonatal red rash
354
HyperIgE type I (Job synd)
Stat3 GOF AD triad: 1. recurrent skin/lung infections (a aureus, a pneumonia, H flu, C albicans) 2. Severe eczema 3. IgE >2000 Retained teeth, scoliosis Absent Th17
355
Hyper IgE type II
DOCK8 Severe eczema Cutaneous viral and bacterial infxns (hpv, hsv, vzv, molluscum) Decreased IgM, NK cells, TRECs Increased eos, B cells, Tregs
356
Hyper IgE type III
Tyk2 - similar to type II with disseminated BCG lymphadenitis, salmonellosis (Tyk2 in il12 signaling to produce ifn-g)
357
Cd40 ligand def (X-linked hyper IgM)
X-linked recessive Biliary tract and liver dz No germinal centers Cryptosporidium Neutropenia IgM normal or high, others decreased Cd40 deficiency is AR
358
Wiscott Aldrich synd
X-linked recessive, Triad: immune def (bacterial/viral), eczema, small plts EBV lymphoma
359
WIP SYnd
WIPF WAS protein absent Thrombocytopenia
360
Hyper IgE syndrome
STAT3 LOF AD cold skin abscesses, pneumatoceles Scoliosis Hard to differentiate from AD STAT3 GOF
361
Netherton syndrome
SPINK5 Icchthyosis Bamboo hair
362
No B cells with enteroviral infections
XLA
363
XLA
Btk gene Sinopulm infxns, GI (enteroviruses) No germinal centers - BTK req'd for survival All Ig decreased Nml T cells Nml pro-B cells - Boys with BTK will have monocytes, but no BTK expression in them
364
AR agammaglobulinemia
Several forms, occur in pre-B cell stage when heavy chain recombines
365
Aid and ung deficiency
High IgM, low IgG/IgA
366
Good syndrome
Adult onset hypogamm, thymoma Decreased B, T, eos, neutros, panhypogamm Thymenctomy does not help immunodeficiency
367
WHIM syndrome
Warts Hypogamm Infections Myelokathexis (neutros retained in BM)
368
Herpes encephalitis genes
Tlr3 Unc93b19 HSE with primary hsv infection Usu 3-6yo Decreased ifn-a and -b
369
Ifn-g mutations
Complete absence = AR + affects extra cellular domain AD = heterozygous, intracellulat domain
370
Osteo w NYB mycobacteria
IFNgR1/2 deficiency
371
C1q leading causes death
Infection, atherosclerosis and MI (C1q plays role in cholesterol clearance)
372
Complement mediated (atypical) HUS
Complement activated on epithelium Treated with c5 blockers (eculizumab and ravilozumab) Microangiopathic hemolytic anemia, thrombocytopenia, kidney injury Disseminated neisserial ingections
373
Receptors HIV uses to enter cells
CCR5 - monocytes/macrophages, acute infection CXCR4 - T cells, advanced hiv dz
374
Western blot hiv testing
Requires 2/3 bands present for + result: Anti-p24, anti-gp41, anti-go160/gp
375
HIV exposed infants tested
At birth, 2-3wks, 1-2mo, 4-6mo
376
Elisa antibody hiv test
High sensitivity/mod specificity Requires confirmatory False + from multiple pregnancies, autoimmune dz, multiple blood Transfusion False -: window period
377
Ritonavir and fluticasone
Ritonavir, inhibits cyp3a4 and cyp2dg, Causing increased levels ICS (fluticasone) to systemic levels Cause Cushing syndrome
378
HLA B5701 and abacavir
Life threatening allergic reaction
379
Immune reconstitution inflammatory syndrome
Decrease in clinical status 4-8wks after ART initiation Reaction of reconstituting immune system and it’s reaction to opportunistic infection with cytokine storm
380
EOE cytokines
IL-5, IL-13, eotaxin-3 (ccl26) Eotaxin3 most overexpressed gene in EoE, receptor is CCR3. Chemotactic for eos
381
Triggers EoE
Milk, wheat, egg, soy
382
Dupilumab effect on EoE
May reverse esophageal dysmotility/dilation
383
FIP1L1-PDGFRA fusion
Myeloproliferative variant HES Mainly men Higher risk cardiac cx Increased serum B12, tryptase Sensitive to imatinib
384
T cell lymphocytic variant (L-HES)
Prominent skin findings (eczema, urticaria) May progress to T cell lymphoma - hypergamm Elevated TARC/CCL17 Aberrant il5 producing T cells Cd3-cd4+ T cells
385
Dx criteria systemic masyocytosis
1 major + 1 minor or 3 minor: Major: bx w dense infiltrates >15 mast cells Minor: - bx >25% mast cells with spindle shape - c-kit mutation (kit D816V) - expression CD2 and/or CD117+ mast cells - tryptase >20
386
Mast cell activation syndrome criteria (mast cell activation not meeting systemic mastocytosis criteria)
3 criteria needed: A- typical s/s systemic mast cell activation (eg anaphylaxis) B - involvement MC with biochemical studies (elevated baseline typtase, urinate metabolites, etc) C- symptomatic response to mast cell stabilizers
387
Ehrlichiosis
Lone star tick SE, south central, mid Atlantic Can trigger HLh Smear showing intreukocytic morulae Tx / tetracyclineor chloramphenicol
388
Mendelian susceptibility to mycobacterial disease (msmd)
Mycobacterial disease clearance depends in ifn-g activating T cells Defects in il-12/-23/ifn-g cause msmd
389
Hep B marker infectivity/viral replication
HBeAg
390
Syphilis stages
Primary - painless chancre o genitals, skin, mucosa Secondary - rash on palms/soles, condyloma lata (warts) in genitals, malaise, fever Tertiary - cv, neuro
391
Syphilis screening
Nontreponemal ab (vdrl, rpr) tests reactivity to antigen followed by more specific treponemal test looking for antibodies (fta-abs, EIA)
392
False positive syphilis testing
Pregnancy Iv drug use Tb, nonsyphillus treponemal, rickettsia, hiv Endocarditis
393
Treating AOM
Any signs in those <6mo B/l involvement in those 6-23mo Rest - shared decision making First line uncomplicated - high dose amox x 10d Other - augmentin
394
Rhinosinusitis acute v subacute v chronic
Acute - up to 4wks Subacute - 4-12wks Chronic - >12 wks
395
Bacterial causes ars
Strep pneumonia Moraxella H flu
396
ARS dx criteria
2 major or 1 major +2 minor Major: Purulenta rhinorrhea Nasal congestion/obstruction Facial congestion/fullness Facial pain/pressure Fever Hyposma/anosmia Minor: Headache Ear ache/pressure/fullness Bad breath Dental oaon Fatigue Cough (post nasal drip)
397
Treatment abrs
Augmentin (amox-clavulanate) High dose augmentin for those at higher risk/higher risk areas Alternative - fluoriquinolone/doxy Alternative children - clinda + ceohalosporin
398
Recurrent sinusitis
>4 episodes/yr
399
Th17 cells
Produce il-17, -22, and synergies with TNF-a and il-1b to enhance inflammation Induced by il-6, tgf-b Survival increased by il-23 Cytokines recruit neutrophils and enhance local innate response
400
CREST
Calcinosis cutis Raynaud’s Esophageal dysmotility Sclerodactyly Telangectasia Sx of sclerosis/crest synd
401
Sjogrens ab
Ana, SS-A (Ro), SS-B (La)
402
Progressive sclerosis and crest syndrome Ab
Anticentromere Ab
403
Rheumatoid arthritis Ab
RF, anti-CCP
404
RF meds
NSAIDs Steroids Dmards - mtx, sulfasalazine, hydroxychloroquine Jak inhibitors (tofacitinib, baricitinib) TNF-a blockers (infliximab, adalimumab) Anti-Il-6 - tocilizumab Ctla-4-Ig - abatacept - ritux
405
Macrophage activation syndrome (mas) and systemic JIA
10% of those with JIA have MAS
406
Chediak Higashi synd
Oculocutaneous albinism Neuro defects, infxn (cutaneous, sino-pulm) with GNR, staph, strep Trafficking protein defect, granules in neutrophils fuse make enlarged granules, can’t move granules
407
Familial HLH screening markers
Perforin and cd107a
408
APECED
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy Chronic mucocutaneous candidiasis, recurrent thrush, dystrophic nails, endocrineopathies (DM, alopecia…) AIRE mutation Anti-interferon omega Ab very specific for test
409
ALPS
Autoimmune lymphoproliferative syndrome - AI cytopenias, LAD, HSM, lymphomas Genes: FAS Dx - high double neg T cell - TCR alpha/beta (CD3+CD4-CD8-), high B12, il-10
410
IPEX
Immunodysregulation polyendocrinopathy enteropathy x-linked Severe diarrhea, for allergy, early onset DM, cytopenias, skin lesions foxp3 (in Tregs) AR
411
Sezary syndrome
Older patients with chronic nonspecific dermatitis or generalized erythroderma Need: Erythroderma >/80% body Clonal TCR rearrangement Sezary count >/1000 or increased cd4 cells with loss cd26 cells
412
Waldenstroms macroglobulinemia
High IgM Assoc w chromosome 6 abnormalities
413
Castlemans disease
Giant cell LN hyperplasia Angiofollicular LN hyperplasia HHV-8 implicated in pathogen May have POEMS syndrome (Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin abnormalities)
414
Acute hemolytic transfusion reactions (htr)
IgM and complement
415
Delayed htr
Minor blood group antigens (eg Rh) 5-10d after transfusion Increased LDH, indirect bili
416
TRALI
Severe resp distress 1-4hrs after Donor Ab directed at recipient neutrophil antigens or HLA determinants
417
Warm reactive AIHA
IgG against RBCs Positive DAT
418
Cold reactive AIHA
IgM binds to I antigen on RBCs at cold temperatures, activates complement
419
Evans syndrome
ITP + AIHA w/o underlying etiology Assoc w PID (eg cvid, alps)
420
Thrombotic microangiopathy
Triad: hemolytic anemia (non immune), thrombocytopenia, renal disease
421
TTP clinical features
Adamts13 deficiency FAT RN fever Anemia (microangiopathic hemolytic) Thrombocytopenia Renal failure Neuro changes
422
Graves dz
TSH receptor Ab Assoc w autoimmune polyglandular syndrome type 2
423
Hashimoto dz
Ab to TPO, TG, TSH receptor Assoc w APS-2
424
Membranous nephropathy
Most common nephrotic syndrome adults Subepithelial Ig deposits activate complement Thickening glomerular basement membrane
425
MPGN
Thickening GBM Assoc w hep c
426
RPGN
Crescentic GN with focal necrotizing lesions Can progress days-wks Adults - pauci-immune Kids - immune complex mediated more common
427
Anti-glomerular basement membrane (anti-gbm) dz
In RPGN or part of Goodlasture’s synd (pulm-renal vasculitic syn) Ab (IgG1 and IgG4) against alpha3 chain of type IV collagen 1/3 perinuclear antineutrophil cytoplasmic ab (pANCA) and cytoplasmic antineutrophil cytoplasmic ab (c-anca)
428
Pemphigus vulgaris
Target desmogleins-1 and -3 and/or desmosome with IgG and C3 In EPIdermis Life threatening Flaccid bullae
429
Bullous Pemphigoid
60-80yo SUB-epidermis Tense bullae on urticarial base Target BPs - BP180 and BP230, hemidesmosome Eosinophilic infiltrate and increased IgE
430
Epidermokysis bullosa acquisita
In areas of trauma Target type VII collagen
431
Celiac dz genetics And testing
HLA DQ2 and DQ8 IgA to tissue transglutaminase or endomysium
432
AI hepatitis Ab types 1 and 1
Type 1: Ss- or dsDNA Smooth muscle Actin Soluble liver or pancreas Ag Type 2: Anti-liver-kidney-microsomes-1 (ALKM-1) Liver-cytosol antigen (ALC-1 or LC1)
433
Primary biliary cirrhosis
Middle aged women HLA A 0201 and HLA DR8 Progressive inflammation of **intra**hepatic ducts —> chronic cholestasis, fibrosis, cirrhosis, failure
434
Primary sclerosing cholangitis (PSC)
Inflammation, fibrosis, bile duct stricture Affects Intra and extrahepatic ducts Men>women Genetics - HLA B8, DR3 Assoc w UC Increased risk cholangiocarcinoma Dx- ercp
435
Autoimmune vs autoinflammatory conditions
Autoinflammatory - innate immune system, no autoantibodies or auto reactive T cells - early age onset - recurrent bouts similar in severity Autoimmune - later onset, have autoantibodies and auto reactive T cells, worse outbreaks over time - activation adaptive immune system
436
FMF
MEFV gene (codes pyrin) - severe mutations - M694V - Tx = daily colchicine which can decrease likelihood amyloidosis Tonsillectomy can be curative
437
TRAPS
Tumor necrosis factor receptor associated periodic syndromes - AD, in TNFRSF1A gene - febrile episodes can last weeks, periorbital swelling, conjunctivitis, pleuritis, HA - amyloidosis - Tx = Il 1 blockers, anakinra, steroids
438
PFAPA
Tx steroids, tonsillectomy Fevers last 3-6d, occur q3-8wks
439
Mevalonate kinase deficiency (Hyper-IgD)
Mutation MVK gene - cholesterol and steroid synthesis pathway Fevers 3-7d, painful LAD, apthous ulcers, and pain, arthritis Flares from stress and vaccinations Tx - steroids, anakinra prn
440
Cryoporin assoc periodic syndromes (CAPS)
Mutations in NLRP3 3 diseases: cinca/nomid = most severe Muckle wells - moderate Familial cold induced autoinflammatory syndrome (FCAS) - mildest Fever, rash, arthralgia, amyloidosis Nomid with dysmorphism, dev delay, bony overgrowth, sensorineural hearing loss
441
CAPS Tx
Il-1 blockade - anakinra, canakinumab
442
Pyogenic sterile arthritis, pyoderma gangrenous, and acne syndrome (PAPA)
AD, mutation in CD2 binding protein 1– prolonged inflammasome activation Early life arthritis Then sterile pyoderna gangrenosum, cystic acne, Pyogenic sterile arthritis Tx - il-1 blockade
443
DIRA deficiency of IL- receptor antagonist
Uninhibited Il-1 activity -> skin and bone disease skin and bone disease Tx - anakinra (anti-il-1) replace lost protein
444
Majeed syndrome
Lipin2 gene Chronic recurrent multi focal osteomyelitis Pain, fever, psoriatic appearing rash and acne Tx - nsaids and steroids
445
Blau syndrome Juveline Systemic granulomatosis
Nod2 GOF - involved in nfkb activation Triad: granulomatous poly arthritis Uveitis Pustular skin lesions Later in life joint swelling and contractures
446
NFkB -opathies
Related to ubiquitous dysregulation Granulomas Oral ulcers Uveitis Immunodeficiency
447
Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome
Interferonopathy - mutations in proteasome system (PSMB8, PSMG2, etc). Proteasomes clear ubq waste proteins Sx - daily fevers, skin plaques, eyelid swelling, ftt, lipodystrophy Autoimmunity - hemolytic anemia, hypothyroid Tx - jak inhibitors interrupt interferón signaling, some success
448
Deficiency of adenosine deaminase 2 (DADA2)
Mutations cecr1 - gene codes for ada2 Def -> adenosine accumulation, neutrophil activation, increased m1 macrophage polarization and inflammatory cytokine production Fevers, lacunar strokes (before age 5), organomegaly, cytopenias, hypogamm, polyarteritis nodosa Tx - steroids, tnf blockade, cyclophosphamide, Def ada1 -> T-B-NK- SCID
449
Amyloidosis
Native proteins that are misfolded and aggregate as insoluble, then accumulate and cause end organ damage
450
Cryoglobulinemia
Immunoglobulins that undergo reversible precipitation at low temps
451
Mixed cryoglobulinemia sx
Meltzers triad: Purpura Arthralgia Weakness
452
Granulomas labs
Macrophage secrete molecules after activation that promote granuloma formation : ACE calcitriol (1,25dihydroxyvitamine d3) Osteopontin Tnf-a
453
Lofgrens syndrome
Self acute limited form sarcoidosis Triad: B/l hilar adenopatía Erythema nodosum Polyarthritis
454
Granulomatosis with polyangitis
Triad sx: Sinus involvement - ulcers, cobblestoning Lungs - nodules, cavities lesions, pulm hemorrhage Kidneys - focal segmental crescentic GN, pauci-immune +/-c-anca, may have p-anca
455
Egpa
Starts with asthma and allergic rhinitis 2- peripheral eosinophilia 3 - small vessel vasculitis dz Eos>1500 P-anca Tx mepolizumab Asthma persists even after vasculitis improved Most common cause mortality - cardiac dz
456
Hyperacute rejection.
Pre-existing Ab Mins-hours
457
Acute cellular rejection
7d-3mo CD8 T cells (type 4 hypersensitivity)
458
Acute antibody mediated
Days-months Antibodies trigger complement, endothelial injry, thrombosis C4d deposition in capillaries (type II and iii hypersens)
459
Chronic rejection
Months-yrs T cells, cytokines Ongoing acute rejection Vascular smooth muscle proliferation, fibrosis, occlusion - cd4 vasculopathy or accelerated graft atherosclerosis
460
Tolerance transplanted graft
Via Tregs
461
Engraftment neutrophils and platelets
Neutro- 3 consecutive days with anc>0.5x10^9 or 1 day >1x10^9 Plt - >20x10^9 in 3 consecutive days
462
Gvhd cells
Donor t cells Il-10, ifn-g, tnf-a
463
Chronic GVH
Cd4 T cell mediated B cells, Th17 Prevent with T cell depletion Occurs >100 days (usu >6mo) Fibrosis and scarring
464
Acute gvh
<100 days Cd45RO T cells Ppx mtx, cyclosporine, tacro, steroids Tissue injury - red angry rash, diarrhea, abd pain, weight loss
465
Sos syndrome
Sinusoids obstruction syndrome After transplant Most often with hematopoietic cell transplantation W/in 29 d transplant: Bili >2 Hepatomegaly/RUQ pain >2-5% wt gain from fluid retention
466
Sweat test result
Cf unlikely sweat Cl /60
467
Ivacaftor Lumacaftor Tezecaftor
Ivacaftor - increases probability cftr channel opening (gating) Lumacaftor - Phe508del corrector, increases production cftr Tezecaftor - F508del corrector facilitates delivery of cftr to cell surface
468
Cockroach allergen
Bla g 1, 2, 4 5 6 9 11 Per a 1
469
Standardized extracts
1. Dust mite 2. Short ragweed 3. Cat 4. Grasses - Bermuda and northern 5 Hymenoptera Extracts standardized by Center for Biologics Evaluation & Research/FDA
470
Dose range allergen proteins in IT
1000-1500 AU/BAU
471
Immuno increases seen in IT
Increase: IgG blocking Ab (first IgG1 then IgG4) IgA in resp secretions Cd4+cd25+ regulatory cells (il-10, tgf-b,) and % cd8 cells Initial increase and then decrease specific IgE Th1 cytokines (Ifn-g, il-12) Increased ifn-g:IL-4 ratio Histamine2 receptor Breg Dc4reg
472
Immune decreases in IT
Seasonal rise specific IgE Low affinity IgE receptor FceRII (cd23) B cell activation markers Basophil hyper reactivity Recruitment eos, basos, mast cells in nose/lung Allergen specific lymphocyte proliferation Th2, Th17, il-2 receptor, NFkB activation, il-8 secretion
473
What slows loss of potency in IT vials
Glycerine - inhibits proteolytic activity
474
Antibacterial in IT vials
Phenol
475
Extracts with proteolytic activity that degrade pollen
Mold, cockroach Don’t mix with pollens, hdm, dander
476
Effective maintenance scit dose aero allergen
5-20ug of major allergen Aka 1000-4000 BAU/AU
477
Maintenance dose venom
Single venom 100ug Mixed vespid 300ug
478
Rate of systemic rxns scit
0.2% of shots end in reaction In 2% of patients 2% severe 2 fatalities/yr
479
SLIT tab let options
5-grass pollen (Northergn grass, Kentucky blue, Timothy, orchard, perennial rye, sweet vernal) Timothy grass Short ragweed HDM
480
SLIT studies
first RCT with Ragweed original studies from Noon & Freemen with timothy grass measuring conjunctival challenges
481
Antihistamines
Stabilize histamine receptors in inactive state
482
Antihistamine to be used in renal and liver impairment
renal - loratadine Hepatic - use fexofenadine Grapefruit juice decreases absorption antihistamines
483
anithistamines with quickest onset
cetirizine and levocetirizine
484
beta agonist ultra long acting
carmoterol, indacaterol - onset action 5 hrs, last >/24 Bulkier the side chain - more selective for B2 receptro larger size terminal amino group - protects from degradation by MAO
485
B agonist adverse effects
tremor, tachycardia, prolonged QTc, MI, transient increased hypoxia hyperglycemia, decreased K+ and Mg++
486
beta agonist resistent
B16 arg/arg homozygotes - agonist receptor downregulation and resistance to SABAs
487
If patient needs B-blocker, prefer cardioseelctive B-B
eg metoprolol, atenolol (not propranolol, etc)
488
how to treat pt on B-b unresponsive to epi
glucagon
489
cystinyl leukotrienes
LTC4, LTD4, LTE4 Form via 5-LO pathway, from LTA4 via LTC4 synthase
490
leukotriene antagonist responses in AERD
1 - improved FEV1 2 - decreased rescue inhaler use 3 - decreased asthma exacerbations
491
what to monitor while on zileuton or zafirleukast
liver function
492
mast cell stabilizers action
Eg cromolyn, nedocromil inhibit IgE-mediated Ca channel activation Increased intracell Ca needed for mast cell degranulation blocks activation neutrophils, eos, etc
493
Muscarinic receptors
M1 - on eos in those w/ copd M2 - inhibitory R on parasymp nerves; dysfunctional M2 causes increase ACh M3 - primary mediator smooth m contraction in airways - concentation bronchi >trachea > alveoli >airway epithelium ACh -> bronchoconstriction, mucus secretion, vasodilation
494
ipratropium bromide use
asthma - decreases hospitalizations COPD - 1st line, also in rhinitis Inhibits both M2 and M3 (muscarinic inhibitor/anticholinergic) quick onset - 7.6mins to 50% maximal broncodilation
495
Tiotropium
longer action than ipratropium - dissociates more slowly than ipra
496
oral steroids cellular effects
Decrease T > B cells, CD4>CD8 Upregulate CXCR4 slight decrease IgG/M Decrease eos, basos, monos Increase neutros (demargination) Innate immunity spared reverse decreased responsiveness to B agonists (increase receptors)
497
STEROID side effects
Stunt growth, Subcaspular posterior catacts Thrush Eye (glaucoma, cataracts, increased P), Endo (DM) Rage, raises BP Osteopenia Immunosuppresion Dysphonia, DM
498
ICS in asthma
does NOT prevent progressive loss lung function
499
Binding affinity GC receptors
mometasone > fluticasone >budesonide > triamcinolone
500
omalizumab indications
asthma >/6yo, evidence perennial aeroallergen (no improved pulm function) CU >/12 Nasal polyps >/18 Black box - anaphylaxis
501
Mepolizumab
Asthma >6yo, eos >150 HES, EGPA, CRSwNP >18yo Warning - herpes zoster
502
Reslizumab
eos asthma >18 (eos >400) IV only Better in obese pts Black box - anaphylaxis
503
Bneralizumab
eos asthma >12yo (eos >300) Kills eos/basos via ADCC
504
TNF-a inhibitors
Infliximab, adalimumab, certolizab, golimumab Block innate system
505
Abatacept, belatacept
Blocks cd28 costimulation (b7-1, -2) Bu
506
Ruxolitinib
Jak1/2 inhibitor
507
Tofacitinib
Jak 1/3 inhibitors Used in RA, psoriatic arthritis, UC
508
Baricitinib
Jak 1/2 inhibitor Used in RA
509
Methotrexate
Inhibits lymphocyte cell replication
510
Azathioprine
Inhibits purine synthesis and metabolism Causes apoptosis T cells, inhibits t and B cell proliferation Urticarial vasculitis, chronic urticaria, glild
511
MMF
Affects purine nt synthesis and metabolism Decreased b and T cell proliferation, decreased Ab production Used in chronic urticaria, organ transplant
512
Cyclosporine
Inhibits Th function as calcineurin inhibitor, inhibits transcriptional factors (eg NFAT that is responsible for IL-2
513
Tacrolimus
Inhibits txnal factors (eg nfat), inhibits T cell activation Used in atopic derm >/2
514
Rapamycin/sirolimus
Inhibits mTOR Inhibits T cell activation, proliferation, Ab production
515
Interferons
Interfere with viral infections Type I - ifn a/b - antiviral Type II - ifn-g - macrophage activating effects; used in CGD Drugs - adverse effects flu like sx
516
CAR-T cells
Chimeric antigen receptor Have engineered receptors to recognize tumor cells For B cell malignancies, (cml and all) Some pts, car T cells become unresponsive over time Increased T cell activation can also lead to cytokine release syndrome
517
3 types gene therapy
1 - gene therapy/addition (introduce gene into cell) 2 - gene editing, site specific (crispr/ Cas9 3 - gene silencing (does not change gene sequencing)
518
IGRT manufacturing method
Isolation- Modified Cohn-Oncley cold ethanol fractionation
519
Dose IV igrt
0.3-0.6g/kg/mo 400-600mg/kg q3-4wks For every 100mg increase —> 121mg increase in IgG trough
520
SQ IGRT dose
100mg/kg/wk
521
IG dose autoimmune
Higher dose - 2g/kg q3-4wks
522
Epi dose
0.01 mg/kg of 1:1000 for SC/IM 0.01 mg/kg of 1:10,000 IV
523
Polysaccharide vaccines
T indepen Pneumovax (23-valent) Meningococcal
524
Conjugated
T-dependent HiB, prevnar-13, meningococcal (menactra, menveo)
525
In functional/anatomical asplenia vaccine recs
Separate pcv13 and menactra by at least 4 wks
526
When to give ab-containing product after live vaccine administration
At least 2 wks
527
Arthus reactions
Severe local reactions after vaccine administration due to high Ab titers Most common after 4th/5th dose DTaP Type iii hypersens - immune complex deposition
528
Gelatin allergy vaccines
In Mmr, vzv, rabies, yellow fever
529
Yeast is in which vaccines
HBV, HPV
530
B cell ID vaccine ppx
Strep pneumonia Flu Menu gococcal HPV
531
T cell PID vaccine ppx
Live vaccines contraindicated Likely ineffective otherwise in complete SCID, questionable in partial defects
532
Contraindicated vaccines in phagocyte disorders
Love bacterial (can receive live viral)
533
Steroid use and vaccines
If >20mg/d x2+wks -> wait 1 mo after stopping steroids
534
Ivig and vaccine administration
If live vaccines given first > wait 2 wks for ivig Ivig given first > wait 8+ months
535
Indications typanostomy tubes
OME 3 episodes/6mo or 4/yr Persistent OME x 3 mo (b/l) or 6 mo (unilateral) Hearing loss
536
Gell-Coombs classification
Type I - anaphylaxis (acute IgE-mediated; requires sensitization) Type II - antibody depen cytotoxic rxns (cytopenias) Type III - immune complex (eg serum sickness) Type 4 - cell-mediated/delayed hypersens
537
Subclassification type 4 gell-Coombs
IVa - th1 (ifn-g) - monocytes/macrophages - eczema, ppd IVb - Th1 (IL-4, -5) - eos - maculopapular, DRESS IVc - CTL (perforin and granzyme) - cd4/8 - bullous to pustular, increased cd8 in skin, SJS, fixed drug eruption IVd - T cells and IL8 - involve PMNs - pustular rash - AGEP
538
Prohapten hypothesis
Most drugs by themselves no immunogenic, only when metabolized to reactive metabolite
539
P-I drug allergy concept
When drug binds to TCR with string enough affinity, esp when interacting with MHC, then may become immunogenic
540
Atopy risk factor for what drug allergies
Latex, radiocontrast
541
MHCs and assoc drug rxns
HLA-B*5701 - abacavir (test mutation before starting) HLA-B*1502 - carbamazepine in Han Chinese (SJS/TEN) HLA-A*3101 - carbamazepine in Europeans HLA-B*5801 - allopurinol SCAR rxns in Asians HLA-B*1301 - dapsone
542
Drug induced hemolytic anemia
Quinidine, methyldooa, pcn
543
Drug induced thrombocytopenia
Vanco, hep (HIT, IgG to hep-plat factor 4) Sulfonamides, propulthiouracil, quinidine
544
Serum sickness (like) rxns (type iii) (Immune complexes)
Occurs 1-2wjs after first exposure or 1-7d in previously sensitized With pcns, sulfonamides, phenytoin Cefaclor most common cause kids Fever, arthralgia, LAD, erythema multiforme/urticaria
545
Arthus rxn (type iii)
Local selling and tenderness, maybe necrosis after vaccination Typically with boosters Onset w/in hours , resolves in days
546
Al drug induced cutaneous lupus
Anti-ro (ssa) -La (ssb) Hctz, CCB, ACE-I, antifungals
547
SJS vs TEN
SJS <10% epidermal detachment TEN >30% involvement Steroids CONTRAINDICATED in TEN Pcn, sulfonamides, anticonvulsants, nsaids, allopurinol Fas/fasL mediated apoptosis epidermal cells, cd8 activation, perforin release Ivig may help (some anti-Fas Ab)
548
DRESS
Anticonvulsants, antimicrobiana, sulfonamides, allopurinol, minocycline Fever, facial edema, LAD, hepatitis Weeks after therapy and May worsen even after Tx d/c
549
MRGPRX2
Mast cell receptor - certain drugs have this as a target, can cause pseudo allergic reactions (anaphylactoid) Eg nmba, fluiroquinolones
550
AGEP
Acute generalized exanthematous pustulosis Pustular skin rash, fever, neutrophilia, eosinophilia Onset 24hrs of drug
551
Predictive value neg skin test to PCN major and minor determinants
97% rule out anaphylaxis potential
552
Pcn major/minor determinants
Major - benzylpenicilloyl polylysine (pre-pen) Minor - pen G, penicilloate
553
Low risk pcn allergy
Mild Non IgE cutaneous sx, IgE rxn >5 yrs ago Unknown rxn
554
Cephalosporin with unique r group
Cefazolin
555
Major sulfonamide common reaction
Tmp/smx in pts with HIV - delayed maculopapular rash - T cell mediated
556
Vanco reaction
VAncomycin May cause IgA bullous dermatitis
557
Most common cause peri operative drug rxns
Quaternary ammonium muscle relaxants (succinylcholine)
558
Bio marker cytokine release syndrome (drug rxn)
IL-6
559
Contraindications desensitizations
Severe cutaneous reactions (eg blistering skin) immune complex mediated reactions - ten/SJS, dress, serum sickness, hemolytic anemia, drug induced hepatitis/nephritis
560
IgE levels for omalizumab
30-700
561
Eerily and Kate phase mediators of SPT
Early - histamine, tryptase, chymase, carboxypeptidase, substance P, calcitonin gene related peptide (cgrp) Late - cd4 T cell Eos
562
Intradermals most useful for
Pcn, chemo, muscle relaxants, insulin, heparin
563
Most reproducible pft and primary outcome in most asthma drug trials
Fev1
564
Factors affecting DLCO
Hgb levels Increased with exercise, supine position, L-R cardiac shunt Decreased by copd/emphysema, bronchiolitis obliterans, ild. May be high in asthmatics
565
Forced oscillation technique
Small P oscillations at mouth transmitted to lungs Measures resistance and reactance For those unable to cooperate with pft
566
Significant response bronchodilator in adults
Increase FEV1 of 12% AND >/200ml
567
Pft in emphysema
Decreased FEV1/FVC with decreased DLCO
568
Methacholine challenge
Concentration of Methacholine that causes decrease in fev1 by 20% = PC20 PC20 of
569
Mannitol v Methacholine
Methach**o**line with high sensitivity, rules **o**ut asthma Mann**i**tol with high specificity rules **i**n asthma (particularly exercise induced)
570
Factors that increase/decrease FeNO
Increase : asthma, atopy, Uris, >12yp, copd exacerbation, Eosinophilic bronchitis Decrease: bronchiectasis, tobacco smoke, drugs (steroids, antileukotriene, NOS inhibitors), exercise, moderate altitude, hypothermia
571
Ciliary structure
Filiar shaft contains fibrils composed of nine outer pairs of microtubules and 2 central microtubules Adjacent doublets connected by dynein arms Microtubules composed of tubulin
572
Kartagener’a synd triad
CRS Sitús inversus Bronchiectasis Auto R Saccharine transit test shows slower mucociliary clearance/transit time Bx preference is from Carina
573
Asthma sputum smear
Charcot Leyden crystals Curschmamms spirals (corkscrew twists of condensed mucus) Creola bodies (clumps sloughed epithelial cells) ECO, MBP
574
Eosinophils in eos asthma Neutrophils in neutrophilic asthma
Eos >3% Neutros > 76%
575
Degree complement activation by Ig in descending order
IgM > IgG3 > IgG2 > IgG2
576
Diagnostic feature ALPS
AlphaBeta double negative T cells (Cd4-cd8-)
577
Cd3- cells
B and NK cells
578
Stem cell surface markers
Cd34+
579
Treg surface markers
Cd3+ cd25+ foxp3+
580
Naive nature B cell surface markers
Cd19+ surface IgM+ IgD+
581
Mature B cell surface markers
Cd19+ cd21+
582
Memory B cell surface markers
Cd19+ cd27+
583
Nk vs NKT cell surface markers
NK: cd45+ cd2+ cd16+ cd56+ NKT: cd45+ cd3+ cd16+ cd56+
584
Receptor in mature B cells that binds EBV and HHV8
CD21/cr2 also binds rhinovirus
585
Adenovirus cell receptor
Cd46
586
Rhinovirus receptor
Cd54
587
CD59
Inhibits MAC in complement (binds c8, c9)
588
LAD1 defect
Defect in common beta chain in CD18
589
LAD2 defect
Defect in CD62E and P (NOT L)
590
Inhibitory cell surface marker B cells
Cd22
591
A4b7 in T cells bind what
MAdCAM-1 in gut
592
Onalizumab binding site
CH3 domain on FREE IgE At FCepsilonRI binding site
593
Core rotors for HIV entry into cells
CCR5, CXCR4
594
Prevnar vs pneumovax
Prevnar - conjugated polysaccharide, B and T cell Pneumovax 23 - unconjugated polysaccharide, B cell only
595
Cd56dim vs bright
Dim - mature NK cells - majority of NK cells, higher cytokinin activity Bright - immature NK cell
596
Catalase + organisms
Staph aureus Salmonella Serrati Pseudomonas
597
Missing factors when ch50 low/ah50 nml
C1q/r/s, c4, c2
598
Missing factors when ch50 nml /ah50 low
Factor B/D, properdin
599
Missing factors when ch50 and ah50 absent
C3, c5-9
600
Acquired vs hereditary complement deficiency
Hereditary - ch50/ah50 absent. Only one component missing Acquired - levels low, not absent Multiple components low
601
How to test for infections in those with CVID, XLA, on IGRT
Ab testing unreliable Use PCR
602
Haller cell
Extension of ethmoid sinus and air cell Along medial floor of orbit Can increase risk acute rhinisinusitis
603
Volumetric sampling methods
Impaction - most common; indoor/outdoor sampling Impingement - liquid impingers draw air particles in; collect bioaerosols Filtration - suck particles through a filter; detect dust, endotoxins, antigens, fungi, microorganisms
604
Durham sampler
Gravitational sampler; simplest method Slides coated w adhesive, exposed x 24h Cheap, durable, no power source needed Biased towards larger particles Cannot determine air concentration ( Don’t know v of air)
605
Settle plates
Sedimentation sampler Particles settle on agar plate, then incubated and counted (bacteria, molds) Identified viable airborn organisms Indoor use only, biased larger particles, can’t determine airborn concentration
606
Slit impactors
Burkhard - suction slit, for pollen and spores, frequently on rooftops, efficient for particles <10um, but need consistent wind speed, sampled from 24h-7d; expensive Allergenico sampler - not wind-oriented, suction sampler collects on lab slides, primarily indoor use
607
Rotating arm impactor
Rotorod - Rods sweep through air to collect particles on surfaces with adhesive tape, Able to calculate air volume and concentration! Not affected by wind Not good for small particles (<10um) eg molds (they air stream around the rods)
608
Sieve impactors
Anderson sieve impinger - series of sieves, air drawn in and passes through stages/sieves with progressively smaller holes, separated based in size Used for culture based sampling fungi Expensive
609
Wind pollen sizes
20-60um
610
Grass pollen
20-45um Smooth surface with one pore
611
Northern grasses
Timothy - Phl p 1-14 orchard rye - Lol p 1-14 fescue bluegrass - Poa p 1-14
612
Southern grasses
Bermuda- cyn d 1-14 Bahia - Pas n 1, 13 Johnson - Sor h 1-14
613
Ragweed
Amb a 1-10, profilin, cystatin Spiny exine (outer surface), 15-25um Pollen-food allergy with banana, cantaloupe, watermelon
614
Mugwort/sage allergen
Art v 1-3, profilin Smooth surface, tricolporate OAS - celery spice, peach, mustard Mugwort celery spice syndrome - celery, coriander, peppers, parsley, fennel
615
Cockleburs
25-30um Similar to ragweed with external spikes, but larger and smaller spines
616
Nettle
One of smallest pollens 12-16um Tri-tetraporate Look wrinkled/air been sucked out of cell
617
Plantain
20-40um Many pores Pore cap makes it look like doughnut
618
Dock/sorrell
20-30um Tricolporate Starch inclusion granules - looks bubbly
619
Ash pollen
Fra a 1 Furrows make square/pentagon appearance
620
Birch
Bet v 1-7 Triporate Looks like lemon when only 2 pores visible Oas - Apple, apricot, carrot, celery, cherry, coriander, fennel, hazelnut, kiwi, nectarine, parsley, parsnip, pear, pepper, plum, peach, potato, walnut
621
Birch OAS mneumonic
Pal, remember the ABC Pear, peach, plum, potato As well as apricot, apple are linked to Birch Along with Celery, cherry, And carrot
622
Mountain cedar
Jun a 1-3 With cypress, juniper Thick outer layer, granular inside, outer layer can break, look like PAC man
623
Oak
Que a 1 Oak, beech, chestnut Triangular, 3 white furrows slightly protruding from surface 25-35um Oak - O with corners - triangle
624
Syacamore
Pla a 1 Round, tricolpate, thin exine (outer covering)
625
Pine
Mickey Mouse Large - 50-100um
626
Maple and box elder
Tricolpate Look like beach balls with coloring
627
Elm
4-7 oval shaped pores Outer surface looks wavy
628
Poplar, willow, cottonwood
Poplar/cottonwood - round, outer granular surface; no furrows Willow - furrows
629
Sweetgum
Soccer ball with many white pores
630
Mulberry
Small 11-20um 2 pores, Look like a lemon from the side (more granular than birch)
631
Walnut hickory pecan
Walnut - Periporate - 9-15 pores
632
Acacia pollen
Covered in nerf pads
633
Alternaria
Club shaped Dry day mold - in hay, grains Alt a 1-12
634
Cladosporium
Sausage chain, budding off Delray day spore - inside and out 6-25um Cla h 1-12
635
Aspergillus
Indoor mold Looks very similar to penicillin Like dandelion puff Asp f 1-22
636
Penicillium
Paintbrush Hypersens pneumonitis Pen ch 13,18,20
637
Helminthosporium, bipolaris
Single spores with thick walls Look like worm Allergic fungal sinusitis
638
Epicoccum
Round multicell dry day spore Dark brown, circular, warts on surface
639
Fusarium
Colorless Wet day spore 20-50um Spindle shaped and curved with tapered ends - string bean
640
Ascomycota
Lots of shapes and sizes 8 ascopores to an ascus
641
Dry day mold spores - on dry, sunny, windy days
ACE Alternaria Cladosporidium Epicoccum
642
Molds at night and high humidity
Ascopores Basidiospores
643
Dust mite cross reacts with shrimp
Der p 10
644
Group 1 dust mite allergens
Der p 1 and Der f 1 89% homology Cysteine proteases Der p/f2 - 80% homology Lipopolysaccharise binding proteins
645
Cockroach allergen
Bla g Per a
646
AQI values standardized for
Ozone, NO2, SO2, CO, PM
647
AQI zones
0-50 - good 51-100 - mod 101-150 - unhealthy for sensitive groups 151-200 - unhealthy 201-300 - v unhealthy 301-500 - hazardous
648
Nitrogen dioxide pollutant
Precursor to o3 Decreased in lung function, increased airway neutrophils, pro inflammatory cytokines Allergen response at 0.4ppm
649
Ozone pollutant
Peaks summer and in afternoon In asthmatics, increases sx, hospitalizations, b agonist use Decreased lung function acutely and chronically, Increases neutrophils in airway, Il-6, Il-8, leukotrienes, Increased airway reactivity and inflammation Antioxidants (alpha-tocopherol, ascorbate) can help decrease ozone response, esp in gtsm1 def children
650
So2 pollutant
Decreased lung function in children Bronchospasm in asthmatics at 0.5ppm, reverses with beta agonists
651
PM pollutant
Increased allergen sensitization Airway inflammation Asthma CV disease Strep pneumonia binding to airway epithelium Pollutants activate innate immunity, increase TLRs and DAMPs -> inflammasome -> il-6, il-8
652
Tobacco smoke
Assoc w recurrent OM, uri, lri, wheezing, cancer Increases th2 and eos
653
Allergens extracts with proteolytic activity
DM, cockroach, mold Can’t mix mold/cockroach with pollens (DM ok with pollen)
654
Dupilumab
eos asthma >6yo AD >/6months. (can cause conjunctivitis) CRSwNP > 18 EOE >12
655
Catalase positive organisms (CGD)
Staphylococcus aureus, Serratia marsescens, Burkholderia cepacia, Nocardia, Aspergillus.
656
HAE ppx in pregnancy
pdC1-INH, subcutaneous
657
Short term HAE ppx prior to sx
pdC1-INH, subcutaneous
658
Epi dosing adults
0.3-0.5 of 1:1,000
659
660
Nemo part of which pathways
NF-KB Ub of Nemo allows IKK-beta to become active —> P inhibitory component and allows NFkB to local size to nucleus
661
Complement deficiency and macular degeneration
Factor H deficiency
662
Stat4, stat6, stat3, stat5 involved with which t cells
TH1 -- STAT3, Tbet TH2 - STAT6, GATA3 TH17 - RORgT, STAT3 Tfh - BCL-6 Treg - STAT5
663
Relative risk formula
Incidence among exposed/incidence unexposed A/(a+b) ———— C/(c+d)
664
Relative risk reduction formula
1-RR (ARC-ART)/ARC